Mon, April 23 – 10 Stories of The Day!
23 Apr, 2018 | 00:04h | UTC
1 – Report: WHO Expert Consultation on Rabies – World Health Organization (free)
News release: WHO publishes new rabies guidelines and recommendations on lifesaving immunization (free)
2 – Simplifying the use of prognostic information in traumatic brain injury – Journal of Neurosurgery
Part 1: The GCS-Pupils score: an extended index of clinical severity (free)
Part 2: Graphical presentation of probabilities (free)
Commentaries: New Glasgow Coma Scale–Pupils Score and Multifactor Probability Outcome Charts for Use in Patients with TBI – Journal of Neurosurgery, via NewsWise (free) AND New scoring system will speed up assessment of brain injuries – OnMedica (free) AND Glasgow Coma Scale Gets an Eye-Opening Update – Medscape (free registration required)
3 – Revised SAGE recommendation on use of dengue vaccine – World Health Organization (free)
Commentaries: A new dengue vaccine should only be used in people who were previously infected, WHO says – Science (free) AND WHO recommends testing before use of Sanofi’s dengue vaccine – Reuters (free)
4 – Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition – Cephalalgia (free PDF) (via @adamcifu)
News release and website: The International Classification of Headache Disorders 3rd edition (free)
Commentary: International Classification of Headache Disorders – The Lancet Neurology (free)
Related Guideline: Bipolar disorder: assessment and management – National Institute for Health and Care Excellence (free)
6 – Diagnosis and Management of Primary Aldosteronism: the Endocrine Society guideline 2016 revisited – European Journal of Endocrinology (free)
7 – Review: Hypokalemia: a clinical update – Endocrine Connections (free)
8 – Role of Immunotherapy in the Treatment of Asthma – Agency for Healthcare Research and Quality (free)
Source: EvidenceAlerts
Editorial: Nitrofurantoin vs Fosfomycin: Rendering a Verdict in a Trial of Acute Uncomplicated Cystitis – JAMA (free)
10 – Efficacy and Safety of Intranasal Esketamine for the Rapid Reduction of Symptoms of Depression and Suicidality in Patients at Imminent Risk for Suicide: Results of a Double-Blind, Randomized, Placebo-Controlled Study – American Journal of Psychiatry (link to abstract – $ for full-text)
Commentaries: Intranasal Esketamine Found Effective in Rapid Reduction of Depression, Suicidal Thoughts – Psychiatric News Alert (free) AND Fast-acting benefits of ketamine for depression and suicidality – American Psychiatric Association, via ScienceDaily (free) AND Ketamine ‘shows promise’ in treating depression – OnMedica (free) AND Ketamine Spray Effective for Suicidality, but Abuse Concerns Linger – Medscape (free registration required)
Related: ‘Cautious Optimism’ Marks Outlook for Ketamine, Mood Disorders – Psychiatric News (free)